angiotensin-converting enzyme inhibitor


Also found in: Dictionary, Thesaurus, Medical, Legal.

angiotensin-converting enzyme inhibitor:

see ACE inhibitorACE inhibitor
or angiotensin-converting enzyme inhibitor
, drug used to reduce elevated blood pressure (see hypertension), to treat congestive heart failure, and to alleviate strain on hearts damaged as a result of a heart attack (see infarction).
..... Click the link for more information.
.
Mentioned in ?
References in periodicals archive ?
Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
Comparative effects of low and high doses of angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group Circulation 1999;100:2312-2318.
An angiotensin-converting enzyme inhibitor for reducing the risk of MI, stroke, and death from cardiovascular causes in people aged 55 and over who are at high risk of a major cardiovascular event because of a history of coronary artery disease, stroke, peripheral vascular disease, or diabetes accompanied by at least one other cardiovascular risk factor.
PHILADELPHIA -- The addition of prednisone to an angiotensin-converting enzyme inhibitor was associated with improved renal survival in a long-term prospective study of patients with proteinuric IgA nephropathy.
Cough and angioedema associated with angiotensin-converting enzyme inhibitor therapy.
Angiotensin-converting enzyme inhibitor therapy ought to be extended to a vastly expanded patient population.
To start treatment according to the algorithm, which called for a low dose (half tablet) of a marketed formulation that combined a diuretic with either an angiotensin-converting enzyme inhibitor or an angiotensin-receptor blocker, physicians could choose among 11 formulations that were on the Canadian market at the time the study began.
In using Lotensin(R), consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, Captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease.
National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure, Arch intern Med 1997;157:2460-2464.
Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin-converting enzyme inhibitor therapy in patients with heart failure: Vasodilator Heart Failure Trial (V-HeFT) Study Group.
In using Lotensin, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, Captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease.

Full browser ?